Co-Encapsulation of Doxorubicin With Galactoxyloglucan Nanoparticles for Intracellular Tumor-Targeted Delivery in Murine Ascites and Solid Tumors

Doxorubicin (Dox) treatment is limited by severe toxicity and frequent episodes of treatment failure. To minimize adverse events and improve drug delivery efficiently and specifically in cancer cells, encapsulation of Dox with naturally obtained galactoxyloglucan polysaccharide (PST001), isolated fr...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Manu M. Joseph, S.R. Aravind, Suraj K. George, Raveendran K. Pillai, S. Mini, T.T. Sreelekha
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2014-10-01
Edice:	Translational Oncology
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S193652331400076X
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!